ๆญฏCan025.PDF

Similar documents
hwp

Annual report of cancer statistics in Korea in

๋ฐœ๊ฐ„๋“ฑ๋ก๋ฒˆํ˜ธ ํ†ต๊ณ„์Šน์ธ๋ฒˆํ˜ธ : Annual report of cancer statistics in Korea in 2008

Lumbar spine


03-์„œ์—ฐ์˜ฅ.hwp

???์ถ??์ˆ

012์ž„์ˆ˜์ง„

untitled

์ „๋ฆฝ์„ ์•”๋ฐœ์ƒ๋ฅ ์ถ”์ •๊ณผ๊ด€๋ จ์š”์ธ๋ถ„์„ : The Korean Cancer Prevention Study-II (KCPS-II)

16(2)-7(p ).fm

878 Yu Kim, Dongjae Kim ์ง€๋ง‰ ์šฉ๋Ÿ‰์ˆ˜์ค€๊นŒ์ง€๋„ ๋ฉˆ์ถค ๊ทœ์น™์ด ๋งŒ์กฑ๋˜์ง€ ์•Š์•„ ์‹œํ–‰์ด ์ข…๋ฃŒ๋˜์ง€ ์•Š๋Š” ๊ฒฝ์šฐ์—๋Š” MTD์˜ ์ถ”์ •์ด ๋ถˆ๊ฐ€ ๋Šฅํ•˜๋‹ค๋Š” ๋‹จ์ ์ด ์žˆ๋‹ค. ์ตœ๊ทผ ์ด SM๋ฐฉ๋ฒ•์˜ ๋‹จ์ ์„ ๋ณด์™„ํ•˜๊ธฐ ์œ„ํ•ด O Quigley ๋“ฑ (1990)์ด ์ œ์•ˆํ•œ CRM(Continu

๋ถ€์†

< FB4EBB1B8BDC320BAB8B0C7BAB9C1F6C5EBB0E8BFACBAB820B9DFB0A320BFACB1B85FBEF6B1E2BAB92E687770>

1..

139~144 ยฟร€ยฐรธยพร ร„ยง

Can032.hwp

(

ๆญฏ1.PDF

44-4๋Œ€์ง€.07์ด์˜ํฌ532~

00์•ฝ์ œ๋ถ€๋ด„ํ˜ธc03้€žํ’š

a02.PDF

ํ•œ๊ตญ์„ฑ์ธ์—์„œ์ดˆ๊ธฐํ™ฉ๋ฐ˜๋ณ€์„ฑ์งˆํ™˜๊ณผ ์—ฐ๊ด€๋œ์œ„ํ—˜์š”์ธ์—ฐ๊ตฌ

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: : Researc

๊น€๋ฒ”์ˆ˜

๋ชฉ ์ฐจ ํšŒ์‚ฌํ˜„ํ™ฉ 1. ํšŒ์‚ฌ๊ฐœ์š” 2. ํšŒ์‚ฌ์—ฐํ˜ 3. ํšŒ์‚ฌ์—…๋ฌด์˜์—ญ/์—…๋ฌดํ˜„ํ™ฉ 4. ๋“ฑ๋ก๋ฉดํ—ˆ๋ณด์œ ํ˜„ํ™ฉ 5. ์ƒํ›ˆํ˜„ํ™ฉ 6. ๊ธฐ์ˆ ์ž๋ณด์œ ํ˜„ํ™ฉ 7. ์‹œ์Šคํ…œ๋ณด์œ ํ˜„ํ™ฉ ์ฃผ์š”๊ธฐ์ˆ ์ž๋ณ„ ์•ฝ๋ ฅ 1. ๋Œ€ํ‘œ์ด์‚ฌ 2. ์ž„์›์ง‚ ์กฐ์ง ๋ฐ ์šฉ๋„๋ณ„ ์ˆ˜ํ–‰์‹ค์  1. ์กฐ์ง 2. ์šฉ๋„๋ณ„ ์ˆ˜ํ–‰์‹ค์ 

Kbcs002.hwp

Treatment and Role of Hormaonal Replaement Therapy

???? 1

( )Jkstro011.hwp

34.๋ฐ•์†Œํฌ.hwp

264 ์ถ•๋˜์–ด ์žˆ์œผ๋‚˜, ๊ณผ๊ฑฐ์˜ ๊ฒฝ์šฐ ๊ฒฐ์ธก์น˜๊ฐ€ ์žˆ๊ฑฐ๋‚˜ ํ๊ธฐ๋ฌผ ๋ฐœ์ƒ ๋Ÿ‰ ์ง‘๊ณ„๋ฐฉ๋ฒ•์ด ์šฉ์ ๊ธฐ์ค€์—์„œ ์ค‘๋Ÿ‰๊ธฐ์ค€์œผ๋กœ ๋ณ€๊ฒฝ๋˜์–ด ์ž๋ฃŒ ๋ฅผ ํ™œ์šฉํ•˜๋Š”๋ฐ ์ œํ•œ์ด ์žˆ์—ˆ๋‹ค. ๋˜ํ•œ 1995๋…„๋ถ€ํ„ฐ ์“ฐ๋ ˆ๊ธฐ ์ข… ๋Ÿ‰์ œ๊ฐ€ ๋„์ž…๋˜์–ด ์ƒํ™œํ๊ธฐ๋ฌผ ๋ฐœ์ƒ๋Ÿ‰์ด ์ด๋ฅผ ๊ธฐ์ ์œผ๋กœ ํฌ ๊ฒŒ ์ค„์–ด๋“ค์—ˆ๋‹ค. ๊ทธ๋Ÿฌ๋ฏ€๋กœ 1996๋…„๋ถ€

A 617

์ž๊ธฐ๊ณต๋ช…์˜์ƒ์žฅ์น˜(MRI) ์ž์žฅ์„ธ๊ธฐ์— ๋”ฐ๋ฅธ MRI ํ’ˆ์งˆ๊ด€๋ฆฌ ์˜์ƒ๊ฒ€์‚ฌ์˜ ๊ฐœ๋ณ„ํ•ญ๋ชฉ์ ์ˆ˜ ์‹คํƒœ์กฐ์‚ฌ A B Fig. 1. High-contrast spatial resolution in phantom test. A. Slice 1 with three sets of hole arr

์ธ๋ฌธ์‚ฌํšŒ๊ณผํ•™๊ธฐ์ˆ ์œตํ•ฉํ•™ํšŒ

<30372EC0CCC0AFC1F82E687770>

๋…ธ์˜๋‚จ

02 AMC News AMC ์นผ๋Ÿผ ๋‚˜์œ ์†Œ์‹์ด ์ข‹์€ ์†Œ์‹? ํ•ด์™ธ ๋ถˆ์šฐํ™˜์ž ์ง„๋ฃŒ๋น„์ง€์› ์ฒซ ์ˆ˜ํ˜œ์ž 3๋ช… ์บ„๋ณด๋””์•„์—์„œ ๋ฐฉ๋ฌธ ์ตœ์žฌ์› ์†Œ์žฅ ๊ฑด๊ฐ•์ฆ์ง„์„ผํ„ฐ ์‹์˜ ๋ถ€์กฑ ๋“ฑ์œผ๋กœ ์ธํ•ด ์ฆ์ƒ์ด ๋‚˜ํƒ€๋‚œ ๋‹ค์Œ์—์•ผ ๋ณ‘์›์„ ๊ฑด๊ฐ• ๊ฒ€์ง„์ด์š”? ๊ดœํžˆ ๋ณ‘์› ๊ฐ”๋‹ค๊ฐ€ ๋‚˜์œ ์†Œ์‹ ๋“ฃ๊ฒŒ ๋ ๊นŒ ์ฐพ์•˜๊ณ , ๊ทธ๋Ÿฌ๋‹ค

ร€รฅยพร–ยฟรยฐรญยฟรซ ยณยปรรถ

< D B4D9C3CAC1A120BCD2C7C1C6AEC4DCC5C3C6AEB7BBC1EEC0C720B3EBBEC8C0C720BDC3B7C2BAB8C1A4BFA120B4EBC7D120C0AFBFEBBCBA20C6F2B0A E687770>

_ p


334 ้€€ ๆบช ๅญธ ๊ณผ ๅ„’ ๆ•Ž ๆ–‡ ๅŒ– ็ฌฌ 55 ่™Ÿ ่ง’ ่ชช ์—์„œ๋Š” ๋ฟ”์ด ๋‚œ ๋ง๊ณผ ๊ณ ์–‘์ด๋ผ๋Š” ๊ธฐํ˜•์˜ ๋™๋ฌผ์„ ์†Œ์žฌ๋กœ ํ•˜์—ฌ ๋‹น๋Œ€ ์ •์น˜ ์ƒ ํ™ฉ์„ ๋น„ํŒํ•˜์˜€๊ณ , ็™ฝ ้ป‘ ้›ฃ ์—์„œ๋Š” ์„ ๊ณผ ์•…์„ ์ƒ์ง•ํ•˜๋Š” ์ƒ‰๊น”์ธ ็™ฝ ๊ณผ ้ป‘ ์ด ์„œ๋กœ ๋ฒŒ์ด ๋Š” ๋ฌธ๋‹ต์„ ํ†ตํ•˜์—ฌ ์˜ณ๊ณ  ๊ทธ๋ฆ„์˜ ๊ฐ€์น˜๊ด€์ด ์ „๋„๋œ ํ˜„์‹ค์„ธ

Analysis of objective and error source of ski technical championship Jin Su Seok 1, Seoung ki Kang 1 *, Jae Hyung Lee 1, & Won Il Son 2 1 yong in Univ

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: * A Analysis of


<342EBEC8BCBABFAD2CB9DAC7E2C1D82E687770>

16(1)-3(๊ตญ๋ฌธ)(p.40-45).fm

hwp

Minimally invasive parathyroidectomy

YI Ggodme : The Lives and Diseases of Females during the Latter Half of the Joseon Dynasty as Reconstructed with Cases in Yeoksi Manpil (Stray Notes w

ePapyrus PDF Document

Journal of Educational Innovation Research 2016, Vol. 26, No. 2, pp DOI: * Experiences of Af

รˆยฒยผยบยผรถ

ํ˜ธ-11

2009;21(1): (1777) 49 (1800 ),.,,.,, ( ) ( ) 1782., ( ). ( ) 1,... 2,3,4,5.,,, ( ), ( ),. 6,,, ( ), ( ),....,.. (, ) (, )

12์ด๋ฌธ๊ทœ

THE JOURNAL OF KOREAN INSTITUTE OF ELECTROMAGNETIC ENGINEERING AND SCIENCE Nov.; 26(11),

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie


04_์ด๊ทผ์›_21~27.hwp


<30382EC0C7C7D0B0ADC1C22E687770>

ํ™ฉ์ง€์›…

ๆญฏ14.์–‘๋ˆ๊ทœ.hwp

7 1 ( 12 ) 1998 ( ) ( ) ( ) ( ) ( ). ( ) ( ). ( ) ( ) ( ). ( ). ( ) ( ) ( ) 3).., 16 ( ) ( ) ( ) ( ) ( ) ( ) ( ). 4). ( ) ( ) ( ),., 4-5, 6-7, 5) 6) (

ํŒจ์…˜ ์ „๋ฌธ๊ฐ€ 293๋ช… ๋Œ€์ƒ ์•™์ผ€ํŠธ+์ „๋ฌธ๊ธฐ์ž๋‹จ ์„ ์ • Fashionbiz CEO Managing Director Creative Director Independent Designer

DBPIA-NURIMEDIA

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: * Review of Research

4.ร†ยฏรรฝb61รจรˆรฑรรธร‡62~772ร‡ร ยฐยฃ

03-ร€รŒรยฆร‡รถ


๋ณด๊ฑด์‚ฌํšŒ์—ฐ๊ตฌ-25์ผ์ˆ˜์ •




์„œ๋ก  34 2

untitled

. 45 1,258 ( 601, 657; 1,111, 147). Cronbach ฮฑ=.67.95, 95.1%, Kappa.95.,,,,,,.,...,.,,,,.,,,,,.. :,, ( )

ยฐร‡ยฐ๏ฟฝยฐรบรรบยบยด6-2รˆยฃ

09รˆยซยผยฎยฟยต 5~152s

<C1A63534C8B820BCBCB9CCB3AA2DC6EDC1FD2E687770>

ยฑร—ยธยฐยธยฎร†รทร†ยฎ ยณยปรรถ5ร‚รท


์ฃผ๊ฐ„๊ฑด๊ฐ•๊ณผ์งˆ๋ณ‘ ์ œ 9 ๊ถŒ์ œ 8 ํ˜ธ ํ•œ๊ตญ์ธ์„ฑ์ธ์—์„œํก์—ฐ๊ธฐ์—ฌ์‚ฌ๋ง๋น„๊ต์œ„ํ—˜ ์งˆ๋ณ‘๊ด€๋ฆฌ๋ณธ๋ถ€์งˆ๋ณ‘์˜ˆ๋ฐฉ์„ผํ„ฐํก์—ฐํํ•ด์˜ˆ๋ฐฉ TF ๊น€์œค์•„ * Abstract Relative-Risk of Smoking-Attributable Mortal

ยฑรจร‡ยฅยณรข

45-51 ยนรšยผรธยธยธ

Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: * The

< FC1F8B9E6B1B3C0B02E687770>

<35BFCFBCBA2E687770>

๋Œ€ํ•œํ•œ์˜ํ•™์›์ „ํ•™ํšŒ์ง€26๊ถŒ4ํ˜ธ-๊ต์ •๋ณธ(1125).hwp

๋‹ฌ์ƒ์‚ฐ์ด ์ดˆ์‚ฐ๋ชจ ๋ถ„๋งŒ์‹œ๊ฐ„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ โ… . ์„œ ๋ก  โ…ก. ์—ฐ๊ตฌ๋Œ€์ƒ ๋ฐ ๋ฐฉ๋ฒ• ้” ์€ 23) ์˜ ไธน ๆบช ์— ์ตœ์ดˆ๋กœ ๊ธฐ ์žฌ๋œ ์ฒ˜๋ฐฉ์œผ๋กœ, ์— ๋ณต์šฉํ•˜๋ฉด ํ•œ ๋‹คํ•˜์—ฌ ๋‚œ์‚ฐ์˜ ์˜ˆ๋ฐฉ๊ณผ ๋ฐ, ๋“ฑ์— ๋„๋ฆฌ ํ™œ์šฉ๋˜์–ด ์™”๋‹ค. ้” ์€ ์ด ๆฏ’ ํ•˜๊ณ  ๋Š” ็”˜ ่‹ฆ ํ•˜์—ฌ ๆฐฃ, ๆฐฃ ๅฏฌ,, ็ต ์˜ ํšจ๋Šฅ์ด ์žˆ

001-ํ•™ํšŒ์ง€์†Œ๊ฐœ(์˜)

๋ชฉ์› ํ•œ๊ตญํ™”- ๋ถ๊ฒฝ์ „์„ ์ค€๋น„ํ•˜๋ฉฐ ์ง€๋‚œํ•ด๋ถ€ํ„ฐ ์‹œ์ž‘ ๋œ ํ•œ๊ตญ์˜ ๋ชฉ์›๋Œ€ํ•™๊ต ํ•œ๊ตญํ™” ์ „๊ณต์˜ ํ•ด์™ธ๋ฏธ์ˆ ์ฒดํ—˜์€ ์ œ์ž์™€ ์Šค์Šน์˜ ๋™ํ–‰ ์†์—์„œ ๋ฏธ์ˆ ๊ฐ€๋กœ ์„ฑ์žฅํ•˜๋Š” ํ•™์ƒ๋“ค์˜ ์ง€์‹์— ์ƒ˜์„ ์ฑ„์›Œ์ฃผ๋Š” ์žฅํ•™์‚ฌ์—…์œผ๋กœ ์ง„ํ–‰๋˜๊ณ  ์žˆ์œผ๋ฉฐ, ํ•œ๊ตญ์˜ ์šฐ์ˆ˜ํ•œ ์ฐฝ์ž‘์ธ๋ ฅ ์–‘์„ฑ์„ ์œ„ํ•ด, ๋ฐฐ์›€์„ ์„œ๋กœ ๋‚˜๋ˆ„๋Š” ์Šค์Šน๋“ค์˜

:,,.,. 456, 253 ( 89, 164 ), 203 ( 44, 159 ). Cronbach ฮฑ= ,.,,..,,,.,. :,, ( )

Journal of Educational Innovation Research 2018, Vol. 28, No. 3, pp DOI: NCS : * A Study on

02์ด์šฉ๋ฐฐ(239~253)ok

,,,.,,,, (, 2013).,.,, (,, 2011). (, 2007;, 2008), (, 2005;,, 2007).,, (,, 2010;, 2010), (2012),,,.. (, 2011:,, 2012). (2007) 26%., (,,, 2011;, 2006;

DBPIA-NURIMEDIA

....(....).hwp

Transcription:

J Korean Cancer Assoc 2001;33(2):136-148 Cancer Incidence in Daegu in 1997 98: The First Results of the Daegu Cancer Registry Choong Won Lee, M.D. 1,4, Mi Young Lee, M.D. 1,4, Hyun Sook Lim, CTR 1,4, S oo Sang S ohn, M.D. 2 Jae Kyu Je on, M.D. 3 and Department of 1 Preventive Medicine, 2 Department of General Surgery, Department of 3 Anesthesia, and 4 Daegu Cancer Registry, Keimyung University College of Medicine, Daegu, Korea Purpose: A po pulatio n-bas ed cance r regis try was set up in January 1, 1997 to es timate the inc ide nce of cance r in Daeg u, So uth Ko rea. Materials and Methods : Data s o urces for cas e-finding and abs tracting we re hos pital inpatie nts, othe r s o urces in hos pitals othe r than inpatie nts, and private pathology labo rato ries. The reg is te red cas es we re matc hed agains t two exte rnal databas es, the death ce rtificate and medical ins urance c laims. Results : A total of 7,837 cases (4,203 males, 3,634 females ) we re regis te red in 1997 98 exc luding 2,718 cases of DCN. The c rude incide nce rates of all cance rs combined we re 170.7/100,000 (AS R 255.0) in males and 149.8 (AS R 154.4) in fe males. In males, the most common cance r was s to mach (47.3, ASR 69.0), fo llowed by liver (28.0, ASR 37.6), lung (26.0, AS R 44.1), colo rectum (14.9, AS R 23.3), urinary bladder (4.5, AS R 7.0) and pros tate (3.5, AS R 7.0). The mos t common cance r in fe males was s to mach (25.8, AS R 26.9), fo llowed by breas t (21.7, ASR 20.4), ce rvix ute ri (21.1, ASR 20.4), co lo rectum (14.9, AS R 16.0), lung (9.9, AS R 11.0), live r (9.3, AS R 10.1), and thyro id (6.1, ASR 5.7). The ove rall pe rce ntage of mic ros co pically ve rified and the DCN% we re 80.3%, 27.7% in males and 88.7%, 20.7% in fe males, res pectively. Conclusion: These res ults s how that the incidence level of all cancers combined in both sexes in Daegu is approac hing that of othe r indus trialized regio ns in As ia as we ll as in the wo rld. (J Korean Cancer Assoc 2001;33:136 148) Key Words : Cancer reg istry, Daeg u (population-based cancer registry) (1).. 1980 WHO (multi-hospital central cancer registry), 194 700-712, Tel: 053-250-7456, Fax: 053-250-7494 1001996. 2000 12 20, 2001 4 23 (2), (3) 1992 95 (4), (5 7). 8 (8,9)... 1997 1 1 1998 12 31 2 1997 98. (Daegu Cancer Registry, DCR) (population-based can-

Choong Won Lee, et al Cancer Incidence in Daegu in 1997 98 137 Fig. 1. Age structure in Daegu, 1995. cer registry) 1997 1 1. 1995(10)2,445,277 ( 1,231,602, 1,213,675 ) Fig. 1. ICD-O-2 /3(11,12). IARC. (12) 1997 1 1 1998 12 31 2.,,,,,,,,,,,, (morphology),, (PRN).,,. (Fig. 2). 8, (inpatients database). (,, CT/MRI,, ).,,,.,.,,. (matching), DCR (internal database). 2 2,. (, ) death certification notification (DCN). (suspense file). (prevalent cases) 1993 1996.

138 J Korean Cancer Assoc 2001;33(2) Fig. 2. Data collection mechanism and input diagram., (13). (microscopic verification%, MV%), (death certificate notification, DCN)%, /(mortality/incidence ratios, MI ratios). MV% CI5 (14) (needle biopsy). 18 (1). CANREG-3 (15). 1997 98 2 7,837 4,203, 3,634. 10 170.7,

Choong Won Lee, et al Cancer Incidence in Daegu in 1997 98 139 47.3 (ASR 69.0). 28.0 (ASR 37.6), 26.0 (ASR 44.1), 14.9 (ASR 23.3), 4.7 (ASR 8.0), 4.5 (ASR 7.0), 4.4 (ASR 7.3), 3.6 (ASR 5.1), 3.5 (ASR 7.0), Non-Hodgkin's lymphoma 3.4 (ASR 4.3), Kaposi's sarcoma Table 1. Average annual age-specific incidence rates, crude rates (all ages), ASR in Daegu 1997 98 by primary site and age in males All AGE Crude ASR ICD SITE 0 0 1 4 5 910 1415 19 20 2425 2930 3435 3940 44 45 49 50 5455 59 60 6465 6970 7475 79 80 ages UNK rate world (10th) Lip 2 0 8.5 14.0 0.1 0.2 C00 Tongue 23 0 0.9 0.6 2.1 2.7 8.6 1.6 13.1 8.5 14.0 0.9 1.2 C01-C02 Salivary gland 11 0 0.8 1.7 0.7 1.1 4.7 2.8 0.4 0.5 C07-C08 Mouth 20 0 0.5 0.4 2.1 3.7 2.2 4.7 5.6 17.5 0.8 1.2 C03-C06 Oropharynx 14 0 0.6 1.4 1.8 1.1 4.7 8.4 8.7 0.6 0.9 C09-C10 Nasopharynx 17 0 0.4 0.4 1.3 0.6 1.4 5.4 4.7 4.4 0.7 0.7 C11 Hypopharynx 13 0 1.1 4.3 6.3 5.6 8.5 0.5 0.7 C12-C13 Pharynx unspec. 5 0 0.4 4.7 2.8 0.2 0.3 C14 Oesophagus 108 0 3.4 5.6 7.3 21.6 31.3 59.0 35.0 94.0 84.3 4.4 7.3 C15 Stomach 1165 0 1.3 1.5 3.8 11.2 20.6 56.8 71.3 116.1 185.6 335.2 455 437.2 632.3 351.2 47.3 69.0 C16 Small intestine 21 0 0.4 0.4 2.2 0.7 0.9 5.4 3.1 2.8 13.1 17.1 0.9 1.1 C17 Colon 178 0 1.3 1.3 3.1 6.2 9.2 14.6 24.8 53.3 67.4 87.4 119.6 140.5 7.2 11.5 C18 Rectum 189 0 0.6 0.5 0.4 0.4 5.3 2.8 11.3 21.0 36.7 47.0 67.4 96.2 85.4 126.4 7.7 11.8 C19-C21 Liver 689 0 1.2 0.5 0.9 2.1 3.9 14.5 36.5 66.4 92.4 138.1 161.3 188.2 183.6 179.4 224.7 28.0 37.6 C22 Gallbladder etc. 116 0 0.4 2.2 4.2 5.5 24.8 39.2 59.0 74.3 51.3 98.3 4.7 8.0 C23-C24 Pancreas 70 0 0.5 0.4 0.9 2.8 4.9 3.7 14.0 14.1 25.3 39.3 59.8 42.1 2.8 4.5 C25 Nose, sinuses etc. 15 0 0.4 1.4 2.7 2.2 4.7 8.4 8.5 0.6 0.9 C30-C31 Larynx 98 0 1.7 3.5 9.1 27.0 43.9 22.5 61.2 42.7 4.0 5.9 C32 Bronchus, lung 640 0 0.4 0.8 0.9 3.9 10.1 13.4 43.9 105.7 200.5 379.2 467.8 478.5 238.8 26.0 44.1 C33-C34 Other Thoracic organs 19 0 0.6 0.4 0.4 0.6 1.1 6.3 14.0 17.5 14.0 0.8 1.4 C37-C38 Bone 21 0 1.1 0.5 2.1 0.4 0.4 0.4 0.9 1.7 0.7 1.8 1.1 4.4 0.9 0.8 C40-C41 Connective tissue 22 0 0.6 0.4 0.8 0.4 0.6 2.1 1.8 2.2 1.6 11.2 8.7 17.1 0.9 1.3 C47;C49 Mesothelioma 1 0 1.6 0.0 0.1 C45 Kaposi's sarcoma 1 0 8.5 0.0 0.1 C46 Melanoma of skin 12 0 0.4 0.9 0.6 0.7 0.9 1.1 4.7 5.6 0.5 0.6 C43 Other skin 57 0 1.7 2.2 2.2 1.4 3.7 9.7 18.8 19.7 26.2 17.1 28.1 2.3 3.4 C44 Breast 2 0 0.7 14.0 0.1 0.2 C50 Prostate 85 0 1.4 5.4 25.1 44.9 65.6 205.1 98.3 3.5 7.0 C61 Testis 8 0 2.5 0.8 0.4 0.7 0.3 0.4 C62 Penis 5 0 0.4 0.9 1.1 2.8 8.5 0.2 0.3 C60 Other male genital 5 0 0.9 1.6 5.6 14.0 0.2 0.4 C63 Bladder 110 0 0.4 0.4 1.7 1.8 3.9 4.9 8.2 17.3 25.1 56.2 43.7 94.0 56.2 4.5 7.0 C67 Kidney etc. 88 0 1.2 0.5 0.5 0.4 0.4 0.9 1.8 3.4 7.1 10. 15.1 14.1 33.7 35.0 25.6 42.1 3.6 C64-C66; 5.1 C68 Eye 4 0 2.5 0.2 0.2 C69 Brain, nervous system 41 0 1.8 0.5 1.7 0.4 1.7 1.3 2.6 2.8 2.1 2.7 3.2 3.1 5.6 8.5 1.7 1.7 C70-C72 Thyroid 37 0 0.4 0.8 0.8 2.2 2.2 1.1 2.1 3.7 4.3 4.7 8.4 4.4 8.5 14.0 1.5 1.7 C73 Other endocrine 9 0 0.6 0.5 0.5 0.9 0.4 1.1 1.6 4.4 0.4 0.4 C74-C75 Hodgkin's disease 5 0 0.5 0.4 0.4 0.4 1.6 0.2 0.2 C81 Non Hodgkin C82-C85; 84 0 1.2 0.5 1.4 1.5 2.5 3.5 3.9 3.4 3.5 5.5 5.4 17.2 19.7 21.9 34.2 28.1 3.4 4.3 lymphoma C96 Multiple myeloma 23 0 0.4 0.6 0.7 1.8 3.2 7.8 16.9 17.5 0.9 1.5 C88;C90 Lymphoid leukaemia 30 0 4.3 1.6 1.8 0.4 0.4 0.8 0.9 0.9 0.7 0.9 1.1 1.6 11.2 1.2 1.5 C91 Myeloid leukaemia 42 0 0.5 1.4 0.9 0.8 2.5 1.3 1.8 2.2 2.8 1.8 4.3 4.7 8.4 8.5 1.7 1.8 C92 Monocytic leukaemia 0 0 0.0 0.0 C93 Other leukaemia 0 0 0.0 0.0 C94 Leukaemia unspec. 10 0 1.8 0.5 0.4 0.4 0.9 0.6 1.6 0.4 0.4 C95 Other &unspecified 88 0 2.6 1.2 0.5 0.8 0.4 0.4 0.9 1.7 3.5 9.1 11.9 29.8 33.7 35.0 59.8 42.1 3.6 5.6 All sites 4203 0 3.0 20.0 8.0 7.0 9.0 11.0 23.0 35.0 72.0 155.0 235.0 380.0 697.0 1137.0 1657.0 1823.0 2290.0 1686.0 170.7 255.0 All sites but C44 4146 0 3.0 20.0 8.0 7.0 9.0 11.0 21.3 35.0 69.8 152.8 233.6 376.3 687.3 1118.2 1637.3 1796.8 2272.9 1657.9 168.4 251.6

140 J Korean Cancer Assoc 2001;33(2) Table 2. Average annual age-specific incidence rates, crude rates (all ages), ASR in Daegu 1997 98 by primary site and age in females All AGE Crude ASR ICD SITE 0 0 1 4 5 910 1415 19 20 2425 2930 3435 3940 44 45 49 50 5455 59 60 6465 6970 7475 79 80 ages UNK rate world (10th) Lip 0 0 0.0 0.0 C00 Tongue 7 0 0.4 0.4 1.3 5.4 4.4 0.3 0.3 C01-C02 Salivary gland 11 0 0.5 0.4 0.9 0.4 1.4 1.8 1.0 1.8 0.5 0.4 C07-C08 Mouth 7 0 0.7 0.9 1.3 3.6 7.8 0.3 0.3 C03-C06 Oropharynx 5 0 0.4 0.7 1.0 2.6 0.2 0.2 C09-C10 Nasopharynx 8 0 1.2 0.9 1.0 1.3 2.4 4.4 0.3 0.3 C11 Hypopharynx 2 0 3.9 4.4 0.1 0.1 C12-C13 Pharynx unspec. 1 0 2.4 0.0 0.0 C14 Oesophagus 14 0 0.9 0.9 1.0 7.2 7.3 3.9 8.9 0.6 0.6 C15 Stomach 626 0 0.9 1.2 7.6 11.8 18.0 23.9 40.9 39.4 69.9 101.1 147.7 193.5 211.8 124.2 25.8 26.9 C16 Small intestine 19 0 0.4 0.4 7.0 5.2 3.6 4.8 3.9 4.4 0.8 0.8 C17 Colon 164 0 0.5 0.8 0.4 4.0 1.1 7.2 15.2 21.0 29.8 52.2 55.6 51.0 57.7 6.8 7.4 C18 Rectum 196 0 0.4 2.6 3.1 4.6 10.8 19.7 36.9 37.6 45.0 53.2 82.4 13.3 8.1 8.6 C19-C21 Liver 225 0 0.8 0.5 0.4 0.8 2.2 3.5 8.0 12.2 18.8 37.9 46.7 68.4 48.4 54.9 39.9 9.3 10.1 C22 Gallbladder etc. 128 0 0.4 1.3 1.1 4.3 9.0 13.0 24.6 37.8 65.3 39.2 71.0 5.3 5.9 C23-C24 Pancreas 59 0 0.4 0.4 0.7 3.6 5.0 6.5 32.4 31.4 27.5 17.7 2.4 2.8 C25 Nose, sinuses etc. 13 0 0.5 0.5 0.4 0.4 1.3 3.6 4.8 3.9 13.3 0.5 0.6 C30-C31 Larynx 13 0 1.1 0.9 2.0 2.6 3.6 2.4 11.8 0.5 0.6 C32 Bronchus, lung 241 0 2.6 2.6 7.4 5.0 9.8 18.0 53.1 77.4 120.9 109.8 79.8 9.9 11.0 C33-C34 Other thoracic organs 24 0 0.6 2.9 4.0 2.6 7.2 12.1 3.9 13.3 1.0 1.1 C37-C38 Bone 19 0 1.5 0.5 0.8 1.3 0.6 1.4 1.8 4.0 1.3 0.8 0.7 C40-C41 Connective tissue 27 0 0.7 1.9 0.4 0.8 1.3 1.3 0.6 0.7 2.0 2.6 5.4 7.3 3.9 1.1 1.1 C47;C49 Mesothelioma 1 0 1.8 0.0 0.1 C45 Kaposi's sarcoma 0 0 0.0 0.0 C46 Melanoma of skin 12 0 0.4 1.4 2.7 1.0 2.6 1.8 3.9 4.4 0.5 0.5 C43 Other skin 61 0 0.5 0.4 0.4 0.4 1.1 3.6 0.9 5.0 3.9 16.2 7.3 51.0 71.0 2.5 2.7 C44 Breast 527 0 1.9 7.6 16.6 29.9 49.0 65.3 69.8 64.9 41.5 30.6 38.7 27.5 26.6 21.7 20.4 C50 Uterus unspec. 7 0 0.9 0.7 0.9 1.0 1.8 3.9 0.3 0.3 C55 Cervix uteri 513 0 0.8 1.5 4.2 16.6 28.2 46.1 51.7 51.0 55.9 73.9 48.6 60.5 51.0 35.5 21.1 20.4 C53 Placenta 2 0 0.5 0.4 0.1 0.1 C58 Corpus uteri 51 0 0.8 0.9 2.2 3.4 5.0 7.2 5.0 3.9 16.2 4.8 3.9 4.4 2.1 2.1 C54 Ovary etc. 116 0 0.7 1.5 2.8 2.7 1.3 3.5 2.2 8.0 10.8 9.0 14.0 11.7 21.6 7.3 3.9 22.2 4.8 4.8 C56 Other female genital 26 0 0.8 0.5 0.9 0.6 1.4 1.8 2.0 6.5 10.8 2.4 3.9 8.9 1.1 1.2 C51-C52; C57 Bladder 35 0 0.4 1.8 3.0 1.3 16.2 19.3 23.5 22.2 1.4 1.6 C67 Kidney etc. 44 0 0.4 3.4 2.2 7.2 5.0 11.7 9.0 9.7 7.8 4.4 1.8 2.0 C64-C66; C68 Eye 3 0 0.4 4.8 0.1 0.1 C69 Brain, nervous system 36 0 3.0 2.7 1.0 2.8 0.8 0.4 2.2 1.3 0.6 2.9 0.9 1.0 2.6 1.5 1.6 C70-C72 Thyroid 147 0 0.7 0.5 2.3 1.9 2.5 7.4 7.0 13.7 10.1 6.3 12.0 18.1 21.6 16.9 7.8 17.7 6.1 5.7 C73 Other endocrine 3 0 1.5 0.7 0.1 0.2 C74-C75 Hodgkin's disease 4 0 0.4 2.6 3.9 0.2 0.2 C81 Non Hodgkin 69 0 1.0 0.5 0.8 0.8 2.6 1.3 2.3 2.2 5.4 9.0 11.7 14.4 16.9 3.9 26.6 2.8 2.9 C82-C85; lymphoma C96 Multiple myeloma 15 0 0.4 1.1 1.4 1.0 5.2 3.6 11.8 0.6 0.7 C88;C90 Lymphoid leukaemia 26 0 2.3 2.0 1.5 0.9 0.8 2.5 0.9 0.4 0.6 0.7 1.0 2.4 1.1 1.2 C91 Myeloid leukaemia 50 0 1.5 1.3 2.0 1.5 1.7 1.3 3.5 1.7 1.4 3.6 4.0 3.9 5.4 2.4 13.3 2.1 2.0 C92 Monocytic leukaemia 0 0 0.0 0.0 C93 Other leukaemia 1 0 0.4 0.0 0.0 C94 Leukaemia unspec. 11 0 3.1 0.8 0.7 0.4 0.4 0.4 0.6 1.0 1.3 1.8 3.9 0.5 0.5 C95 Other & unspecified 65 0 2.3 0.7 0.5 0.5 0.4 0.4 1.3 1.1 5.7 4.5 7.0 7.8 18.0 24.2 15.7 8.9 2.7 3.0 All sites 3634 0 3.0 14.0 10.0 11.0 15.0 19.0 35.0 77.0 119.0 182.0 256.0 295.0 417.0 531.0 742.0 830.0 847.0 723.0 149.8 154.4 All sites but C44 3573 0 3.0 14.0 10.0 11.0 14.5 18.6 34.6 77.0 118.6 180.9 252.4 294.1 412.0 527.1 725.8 822.7 796.0 652.0 147.3 151.7

Choong Won Lee, et al Cancer Incidence in Daegu in 1997 98 141 1 (Table 1). 10 149.8, 154.4. 25.8 (ASR 26.9) 2 21.7 (ASR 20.4). 21.1 (ASR 20.4), 14.9 (ASR 16.0), 9.9 (ASR 11.0), 9.3 (ASR 10.1), 6.1 (ASR 5.7), 5.3 (ASR 5.9), 4.8 (ASR 4.8), Non-Hodgkin's lymphoma 2.8 (ASR 2.9) (Table 2). 1997 98 2. 84.4%. 80.3%, 88.7%. 100%, Hodgkin's disease,. 57.7%, 34.9%, Table 3. Percentage of cases registered with microscopic verification of diagnosis (MV%), and death certification notification (DCN (%)), mortality/incidence ratio percent by site and sex 1997 98, Daegu Cancer Registry Sites MV %* DCN % M : I (%) Males Females Total Males Females Total Males Females Total Pharynx etc. 95.3 100.0 96.2 11.5 6.8 10.6 36.5 43.9 27.7 Oesophagus 97.4 93.3 88.1 25.0 28.6 25.4 82.1 48.1 78.7 Stomach 95.1 95.2 95.1 21.0 27.2 23.3 52.6 66.3 57.4 Small intestine 90.9 89.5 90.2 15.4 9.5 12.8 Colon 91.8 88.5 90.2 19.1 27.9 23.6 46.2 64.2 55.0 Rectum 93.3 96.4 94.9 15.8 13.2 14.5 41.1 33.6 37.4 Liver 30.9 36.4 32.3 39.8 41.2 40.1 106.1 114.3 108.3 Gallbladder 55.6 59.7 57.7 38.1 29.5 33.9 102.8 78.5 90.2 Pancreas 31.4 39.0 34.9 54.8 49.1 52.4 191.4 140.8 165.9 Larynx 92.9 85.7 92.0 26.7 30.0 27.1 55.8 74.2 57.7 Bronchus, Lung 88.5 79.9 86.2 30.4 39.3 33.1 93.5 103.6 96.3 Bone 95.5 95.5 95.5 24.1 18.5 21.4 54.1 36.0 47.5 Connective tissue 90.9 96.3 93.9 18.5 3.6 10.9 Melanoma of skin 100.0 100.0 100.0 7.7 7.7 7.7 Other skin 96.6 98.4 97.5 4.9 7.5 6.3 Breast 100.0 96.4 96.5 7.2 7.2 17.7 17.7 Cervix uteri 96.6 96.6 4.2 4.2 10.9 10.9 Uterus unspec. 85.7 85.7 75.9 75.9 Corpus uteri 96.2 96.2 3.7 3.7 5.9 5.9 Ovary 92.4 92.4 9.2 9.2 0.0 0.0 Prostate 90.6 90.6 18.1 18.1 31.3 31.3 Bladder 85.5 82.9 84.8 16.0 18.6 16.7 28.0 35.3 29.7 Kidney etc. 87.5 80.8 85.0 15.4 16.7 15.8 35.0 43.5 37.9 Brain, nervous system 81.4 83.3 82.3 40.3 52.6 46.6 117.0 131.8 126.0 Thyroid 84.6 93.3 93.5 5.1 4.5 4.6 13.5 6.1 7.6 Non Hodgkin lymphoma 100.0 87.0 94.1 26.3 22.5 24.6 58.5 48.6 53.6 Hodgkin's disease 100.0 100.0 100.0 Multiple myeloma 95.7 88.2 92.5 14.8 22.7 18.4 58.6 54.9 55.3 Lymphoid leukaemia 90.0 100.0 94.6 16.7 21.2 18.8 40.6 30.0 35.7 Myeloid leukaemia 95.3 98.0 96.8 18.9 23.9 21.7 57.3 41.2 48.9 Leukaemia unspec. 90.9 81.8 86.4 69.7 67.6 67.2 345.1 329.6 332.4 All sites 80.3 88.7 84.4 27.7 20.7 25.5 70.6 50.9 61.5

142 J Korean Cancer Assoc 2001;33(2) 32.3%. DCN 25.5%, 27.7%, 20.7%. 3.7% 4.2%, 4.6%. 10%,,. 75.9%, 67.2%. 30% (52.4%), (40.1%), (33.9%), (33.1%). 18.5%, 3.6%. / 70.6%, 50.9%. 100% 345.1%, 191.4%, 117.0%, 106.1%, 102.8%. 329.6%, 140.8%, 131.8%, 114.3%, Fig. 3. Age-specific curves for all sites, lung, and selected female cancers, 1997 98, Daegu Cancer Registry. Table 4. Number of cases registered by other sources and local laboratories alone by site and sex Other sources Local laboratories Sites Males Females Total Males Females Total Stomach 111 (31.5) 48 (15.0) 159 (23.6) 57 (74.0) 35 (29.7) 92 (47.2) Colorectum 41 (11.6) 44 (14.4) 85 (12.6) 12 (15.5) 13 (11.0) 25 (12.8) Liver 23 (6.5) 5 (1.5) 28 (4.1) Gallbladder 10 (2.8) 7 (2.1) 17 (2.5) Larynx 13 (3.6) 3 (0.9) 16 (2.3) Lung 41 (11.6) 21 (6.5) 62 (9.2) 1 (1.3) 1 (0.8) 2 (1.0) Other skin 14 (3.9) 15 (4.6) 29 (4.3) 2 (2.6) 9 (7.6) 11 (5.6) Breast 43 (13.4) 43 (6.3) 23 (19.5) 23 (11.7) Cervix uteri 59 (18.4) 59 (8.7) 35 (29.7) 35 (17.0) Prostate 12 (3.4) 12 (1.7) Bladder 18 (5.1) 5 (1.5) 23 (3.4) 1 (0.8) 1 (0.5) Thyroid 4 (1.1) 17 (5.3) 21 (3.1) Non Hodgkin lymphoma 9 (2.5) 6 (1.8) 15 (2.2) Leukaemia 11 (3.1) 7 (2.1) 18 (2.6) Others 45 (12.7) 40 (12.5) 85 (12.6) 5 (6.5) 1 (0.8) 6 (3.1) All sites 352 (100.0) 320 (100.0) 672 (100.0) 77 (100.0) 118 (100.0) 195 (100.0)

Choong Won Lee, et al Cancer Incidence in Daegu in 1997 98 143 103.6% 78.5% 100%. 13.5%, 6.1%. 61.5% (Table 3). 5 9 75 79. 45 49. 40 45, 75 79, 70 74. 20 24 50 54, 60 64. 15 19 65 69, 70 79 80 (Fig. 3). 672, 195 2 8.6%, 2.5%. (31.5%) (11.6%), (11.6%), (18.4%), (15.0%), (14.4%), (13.4%). Table 5. Comparisons of major cancers among cancer registries by sex (ASR world) Sites LA Korean DCR* Kangwha Japan Shanghai migrants (97 98) (86 92) (1995) (88 92) (88 92) Males All sites 255.0 201.7 188.8 265.8 230.5 Oesopahgus 7.3 10.2 6.0 10.0 12.5 Stomach 69.0 65.9 35.5 66.5 46.5 Colon 11.5 4.5 14.1 30.3 12.2 Rectum 11.8 8.3 8.1 17.7 9.3 Liver 37.6 27.7 23.9 25.5 28.2 Gallbladder etc. 8.0 4.8 2.7 6.7 2.5 Pancreas 4.5 7.2 4.8 9.2 6.3 Larynx 5.9 1.4 5.5 2.9 3.3 Bronchus, lung 44.1 33.8 36.7 36.6 56.1 Prostate 7.0 0.9 10.2 10.2 2.3 Bladder 7.0 3.1 5.4 8.2 6.9 Kidney etc. 5.1 1.8 6.1 6.3 2.9 Females All sites 154.4 110.7 138.1 160.6 154.3 Stomach 26.9 25.0 16.2 27.1 21.0 Colon 7.4 2.3 8.2 17.3 10.8 Rectum 8.6 5.3 6.9 8.5 7.3 Liver 10.1 7.7 5.5 7.7 9.8 Gallbladder etc. 5.9 3.8 6.3 5.5 3.6 Pancreas 2.8 2.7 5.4 4.9 4.1 Bronchus, lung 11.0 8.4 12.3 10.7 18.2 Breast 20.4 7.1 21.4 30.8 26.5 Cervix uteri 20.4 21.8 13.4 8.5 3.3 Ovary etc. 4.8 2.8 4.9 6.4 5.8 Thyroid 5.7 6.0 4.8 5.6 3.0

144 J Korean Cancer Assoc 2001;33(2) 54.8%, 60.6%. 195 77, 118. 74.0%, 15.5% 89.6%. 29.7%, 29.7%, 19.5%, 11.0%89.8% (Table 4).... 201.7, 110.7, LA 188.8, 138.1.. 7.120.4. LA 69.0, LA 35.5, 37.6, LA 23.9. 20.4, 21.4,, 26.9 16.2, 10.1 5.5, 20.4 13.4...... (Table 5).,, (13).. CI5 6 (14),..,,. 1995 (16) (14).,,., (13). (death certificate method) (13). DCN%. 4820 1997 98 1149 (23.8%), 953 (19.8%) 2718 DCN (56.4%). DCN% 25.5% ( 27.7%, 20.7%). Spain Torragona 1980 50%, 39% 10 13%, 11%(13).. DCO%5% (8), 1995(16) 17.2%, 16.9%. / (M I ratio) 47.5%. 300%, (13). (13) 55.0%, 37.4%. 70.6%, 50.9%, CI5 7 (8) Osaka67%, 59%, SEER 42%, 43%. -

Choong Won Lee, et al Cancer Incidence in Daegu in 1997 98 145 (13). 5 9 (17).,,, (13). -, 50, 45 50, 50. 15 24,.,., (C26, C42, C48, C76, C77, C80) 88, 65 2.0%, 1.8%. 10 5.6, 3.0. CI5 7 (8) Osaka4.2, 2.9, Khon Kaen 23.3, 14.0, SEER 9.2, 7.1, 12.5, 11.0.. 3.,, 54.8%,,,, 60.6%,, 89.6%,,,, 89.8%.,,,,. 1996 2824, 1997 3741 917..,. 1993 1996, 1997 121, 1998 177, 298....,,, (17)., 1995 (18) 55,016... 255.0, 154.4.. CI5 7 (8) 163 New Mexico 255.0, 253.8, 256.3. Shanghai 154.3, Yamagata, Osaka 153.8, 155.5. 190.0 230.5, 102.9 154.3, 1995(16) 265.8, 160.6. 1995-1996 269.8, 198.3 (19). (1986 92 ) LA (1988 92 )

146 J Korean Cancer Assoc 2001;33(2).,,,,,. LA.,. 1990 73%1 (20) (acculturation).,,,,,.., 7.1 20.4, LA 21.4, 26.5, 30.8. ( over-diagnosis bias ). 66.5, 27.1. ( pseudo-disease ) (21) (22) 10 1990 31.5 1999 24.0 23.8%,. 2,, LA. (23),.,,, (13)..,.,... 10% (23).,,.,.,,, 2...,,,,,,..

Choong Won Lee, et al Cancer Incidence in Daegu in 1997 98 147 ( ) 1. Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG. Cancer Registration: Principles and Methods. Lyon; IARC Scientific Publications No. 95, 1991. 2. Park CH. Central Multi-hospital Cancer Registry in Korea. Proceedings of the 4 th Cancer Registry Symposium; 2000 Oct 24; Ilsan, Korea: Korean Association for Cancer Registry and Korean Association of Medical Records, 2000. 3. Kim J, Park I, Ahn Y, Shin M, Ahn D, Kang T, Ko U, Ku P, Kim K, Kim K, Kim N, Kim D, Kim D, Kim B, Kim S, Park C, Min J, Park T, Woo B, Yoo H, Lee S, Lee S, Cho K, Joo H, Ham E. 1991 cancer incidence in Seoul, Korea: Results of the implementation study of the Seoul Cancer Registry. J Korean Med Sci 1995;10:74-84. 4. Group for Seoul Regional Cancer Registration. Cancer facts and estimates, Seoul, Korea, 1992-1995. 1998. 5. Shin H, Lee D, Park T, Ahn D, Ahn Y, Jeung D. Development of procedures of cancer ascertainment in Pusan city area. J Korean Cancer Assoc 1996;28:943-950. 6. Choi J, Sohn S, Na B, Sun B, Park K, Kweon S, Im J, Kim Y, Hwang T. A feasibility study for the implementation of Kwangju Cancer Registry (KCR). J Korean Cancer Assoc 1999;31:749-757. 7. Lee D, Shin H, Ahn D, Chun B, Kam S, Ahn Y. Accuracy of cancer death certificates in Korea. J Korean Cancer Assoc 2000;32:210-219. 8. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents Vol. VII. Lyon; IARC Scientific Publications No. 143, 1997. 9. Kim SY, Ohrr H, Kang HG, Kim SI, Yi SW. Cancer incidence in Kangwha County (1986-1992). Korean J Prevent Med 1999;32:482-490. 10. Korea National Statistical Office. 1995 Population Census Report, Vol II, City and Provinces, Daegu. 1997. 11. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology. 2 n d ed., Geneva; World Health Organization, 1990. 12. Esteban D, Whelan S, Laudico A, Parkin DM. Manual for Cancer Registry Personnel. Lyon; IARC Technical Report No. 10, 1995. 13. Parkin DM, Chen WW, Ferlay J, Galceran J, Storm HH, Whelan SL. Comparability and Quality Control in Cancer Registration. Lyon; IARC Technical Report No. 19, 1994. 14. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents Vol VI. Lyon; IARC Scientific Publications No. 120, 1992. 15. Olivier S, Parkin DM. CANREG. Cancer Registration Software for Microcomputers. Lyon; IARC Internal Report No. 92/004, 1992.

148 J Korean Cancer Assoc 2001;33(2) 16. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1995: Estimates based on data from nine population-based cancer registries. Jpn J Clin Oncol 2000;30:318-321. 17. Aitio A, Day NE, Heseltine E, Kaldor J, Miller AB, Parkin DM, Riboli E. Cancer: Causes, occurrence and control. Lyon; IARC Scientific Publications No. 100, 1990. 18. Korean National Statistical Office. Districts/sex/no. of foreigners by age (Population Census), Average age of first marriage, divorce and remarriage. Available from: URL: http:// www.nso.go.kr/kosisdb, 2000. 19. Hong Kong Cancer Registry. Cancer incidence and mortality in Hong Kong 1995-1996, 2000. 20. West DW, Le GM, Lin SS. Ethnicity and cancer: Asian migrant data and directions for future research. Proceedings of the 22 n d Annual Meeting of the International Association of Cancer Registries; 2000 Nov 10-12; Khon Kaen, Thailand: International Association of Cancer Registry, 2000. 21. Everett SM, Axon ATR. Early gastric cancer: Disease or pseudo-disease? Lancet 1998;351:1350-2. 22. Korean National Statistical Office. 1999 Annual Report on the cause of death statistics. 2000. 23. Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2 n d ed. New York: Oxford University Press, 1996:813-840, 1370-1387.